esyHealth Belgium SRL
esyHealth Belgium reported total assets of 6,847 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jun 2026).
The score of esyHealth Belgium shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
esyHealth Belgium's annual accounts
| 2025 | |
|---|---|
| Net result | −802 € |
| Equity | 4,198 € |
| Cash | 4,909 € |
| EBITDA | −550 € |
| Total assets | 6,847 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jun 2026
esyHealth Belgium's financial analysis
- Solvency61.3%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of esyHealth Belgium
esyHealth Belgium's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1025.747.284
- VAT number
- BE1025747284
- Peppol
- Registered · 0208:1025747284 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Jul 2025
- Registered office
- 1300 Wavre
- Latest accounts
- 2025 · filed on 02 Jun 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
esyHealth Belgium (SRL) has been based in Wavre since 2025, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net loss of 802 € and equity of 4,198 €; its revenue is not published. Its solvency stands at 61.3%, above the median of its sector (58.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to esyHealth Belgium
Companies in the same business, of comparable size and area, outside its group.
- Pharmaplex Research and experimental development on natural sciences and engineering Wezembeek-Oppem · balance sheet 482,967 €
- Ennovum Research and experimental development on natural sciences and engineering Temse · balance sheet 14,575 €
- OGO Research and experimental development on natural sciences and engineering Comblain-au-Pont · balance sheet 4,038 €
- VVnet Research and experimental development on natural sciences and engineering Ghent · balance sheet 19,002 €
- BSOLUTIONS Technique et Innovation Research and experimental development on natural sciences and engineering Gembloux · balance sheet 2,832 €
- PR Consult Research and experimental development on natural sciences and engineering Namur · balance sheet 35,375 €
- KST R & D Research and experimental development on natural sciences and engineering Liège · balance sheet 65,816 €
- IuMeDa Research and experimental development on natural sciences and engineering Leuven · balance sheet 66,280 €
Frequently asked questions about esyHealth Belgium
What is the revenue of esyHealth Belgium?
esyHealth Belgium files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of esyHealth Belgium?
In Belgium, the VAT number is the company number prefixed with BE: BE1025747284 for esyHealth Belgium, if the company is VAT-registered. Its company number (CBE) is 1025.747.284.
Where is the registered office of esyHealth Belgium?
According to the CBE register, the registered office of esyHealth Belgium is in 1300 Wavre.
What is the equity of esyHealth Belgium?
At the close of the 2025 financial year, the equity of esyHealth Belgium amounts to 4,198 €, a solvency of 61.3% of total assets.
Who manages esyHealth Belgium?
The register lists 1 active mandates at esyHealth Belgium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of esyHealth Belgium
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →